Nautilus Biotechnology In... (NAUT)
NASDAQ: NAUT
· Real-Time Price · USD
0.70
-0.01 (-2.06%)
At close: Jun 23, 2025, 3:59 PM
0.69
-0.74%
After-hours: Jun 23, 2025, 05:54 PM EDT
-2.06% (1D)
| Bid | 0.68 |
| Market Cap | 88.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -68.66M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -1.29 |
| Forward PE | -1.07 |
| Analyst | Hold |
| Ask | 0.76 |
| Volume | 887,137 |
| Avg. Volume (20D) | 191,606 |
| Open | 0.71 |
| Previous Close | 0.71 |
| Day's Range | 0.69 - 0.74 |
| 52-Week Range | 0.66 - 3.09 |
| Beta | 1.25 |
About NAUT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAUT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAUT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-18.18%
Nautilus Biotechnology shares are trading lower. T...
Unlock content with
Pro Subscription
1 week ago · https://www.defenseworld.net
26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLCSquarepoint Ops LLC acquired a new position in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) in the fourth quarter, according to the company in its most recent 13F filing wi...
1 month ago · seekingalpha.com
Nautilus Biotechnology, Inc. (NAUT) Q1 2025 Earnings Call TranscriptNautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Ji-Yon Yi - Head, Investor Relations Sujal Patel - Co-Founder & Chief Execut...